Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil plus propofol versus sufentanil plus propofol for sedation during fiberoptic bronchoscopy
ChiCTR2100041885Phase 4Recruiting
- Sponsor
- Taizhou People's Hospital
- Start
- Dec 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of alfentanil, propofol and sufentanil in Conditions requiring fiberoptic bronchoscopy (2 arms), sponsored by Taizhou People's Hospital. Primary endpoint: Incidence of intraoperative respiratory depression. Started Dec 2020; status: recruiting.
02
Drugs
alfentanilpropofolsufentanil
03
Conditions
Conditions requiring fiberoptic bronchoscopy
Beyond the preview
Go deeper on ChiCTR2100041885.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041885.